Related references
Note: Only part of the references are listed.Development of an ErbB4 monoclonal antibody that blocks neuregulin-1-induced ErbB4 activation in cancer cells
Shogo Okazaki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
HER3, but Not HER4, Plays an Essential Role in the Clinicopathology and Prognosis of Gastric Cancer: A Meta-Analysis
Guo-dong Cao et al.
PLOS ONE (2016)
Neuregulin expression in solid tumors: Prognostic value and predictive role to anti-HER3 therapies
Alberto Ocana et al.
ONCOTARGET (2016)
Human epidermal growth factor receptor 4 (HER4) is a favorable prognostic marker of breast cancer: a systematic review and meta-analysis
Jue Wang et al.
ONCOTARGET (2016)
A Retrospective Analysis for Patients with HER2-Positive Gastric Cancer Who Were Treated with Trastuzumab-Based Chemotherapy: In the Perspectives of Ethnicity and Histology
Jun Ho Yi et al.
CANCER RESEARCH AND TREATMENT (2016)
Prediction of Cancer Incidence and Mortality in Korea, 2016
Kyu-Won Jung et al.
CANCER RESEARCH AND TREATMENT (2016)
Gene copy number gain of EGFR is a poor prognostic biomarker in gastric cancer: evaluation of 855 patients with bright-field dual in situ hybridization (DISH) method
Eiji Higaki et al.
GASTRIC CANCER (2016)
Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival
Xiao Xiao He et al.
JOURNAL OF CLINICAL PATHOLOGY (2015)
Recent advances in the HER2 targeted therapy of gastric cancer
Tasuku Matsuoka et al.
WORLD JOURNAL OF CLINICAL CASES (2015)
Neuregulin 1 Expression Is a Predictive Biomarker for Response to AV-203, an ERBB3 Inhibitory Antibody, in Human Tumor Models
Kristan Meetze et al.
CLINICAL CANCER RESEARCH (2015)
Antibody targeting of HER2/HER3 signaling overcomes heregulin-induced resistance to PI3K inhibition in prostate cancer
Jayakumar S. Poovassery et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Overexpression of NRG1 promotes progression of gastric cancer by regulating the self-renewal of cancer stem cells
Myoung-Eun Han et al.
JOURNAL OF GASTROENTEROLOGY (2015)
Assessment and prognostic analysis of EGFR, HER2, and HER3 protein expression in surgically resected gastric adenocarcinomas
Daoqiang Tang et al.
ONCOTARGETS AND THERAPY (2015)
Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer
Siti Norasikin Mohd Nafi et al.
Oncotarget (2015)
Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer
Keigo Mitsui et al.
BMC CANCER (2014)
Immunohistochemical analysis of RTKs expression identified HER3 as a prognostic indicator of gastric cancer
Akira Ema et al.
CANCER SCIENCE (2014)
Prognostic value of epidermal growth factor receptors in gastric cancer: a survival analysis by Weibull model incorporating long-term survivors
Alexandre Andrade Anjos Jacome et al.
GASTRIC CANCER (2014)
Engineering multivalent antibodies to target heregulin-induced HER3 signaling in breast cancer cells
Jeffrey C. Kang et al.
MABS (2014)
HER2 Status in Colorectal Cancer: Its Clinical Significance and the Relationship between HER2 Gene Amplification and Expression
An Na Seo et al.
PLOS ONE (2014)
Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast Cancer
Jessica J. Tao et al.
SCIENCE SIGNALING (2014)
Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration
Jonathan W. Haskins et al.
SCIENCE SIGNALING (2014)
The localization of HER4 intracellular domain and expression of its alternately-spliced isoforms have prognostic significance in ER+HER2-breast cancer
Saori Fujiwara et al.
ONCOTARGET (2014)
Unraveling trastuzumab and lapatinib inefficiency in gastric cancer: Future steps (Review)
Shouji Shimoyama
MOLECULAR AND CLINICAL ONCOLOGY (2014)
Heregulin induces resistance to lapatinib-mediated growth inhibition of HER2-amplified cancer cells
Yuji Sato et al.
CANCER SCIENCE (2013)
An heregulin-EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+breast cancer models
Wenle Xia et al.
BREAST CANCER RESEARCH (2013)
Current status of targeted therapies in advanced gastric cancer
Ferdinando De Vita et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer
Han Suk Ryu et al.
HUMAN PATHOLOGY (2012)
Expression of NRG1 and its receptors in human bladder cancer
J. A. Forster et al.
BRITISH JOURNAL OF CANCER (2011)
Neuregulin-1-Mediated Autocrine Signaling Underlies Sensitivity to HER2 Kinase Inhibitors in a Subset of Human Cancers
Timothy R. Wilson et al.
CANCER CELL (2011)
Novel anticancer targets: revisiting ERBB2 and discovering ERBB3
Jose Baselga et al.
NATURE REVIEWS CANCER (2009)
The ERBB3 receptor in cancer and cancer gene therapy
G. Sithanandam et al.
CANCER GENE THERAPY (2008)
High Expression of HER3 Is Associated with a Decreased Survival in Gastric Cancer
Mikiko Hayashi et al.
CLINICAL CANCER RESEARCH (2008)
Differential nuclear localization and kinase activity of alternative ErbB4 intracellular domains
M. Sundvall et al.
ONCOGENE (2007)
Role of heregulin in human cancer
M. Breuleux
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Roles for neuregulins in human cancer
C Stove et al.
CLINICAL & EXPERIMENTAL METASTASIS (2004)
The ErbB receptors and their role in cancer progression
T Holbro et al.
EXPERIMENTAL CELL RESEARCH (2003)
Share Paper
